Even if we can't have the kind of live sports we had before the virus, there are several things teams and leagues can do better prepare to reopen, write Richard Florida, Lee Igel, Art Caplan and Patrick Adler.
State officials have previously lamented shortages of supplies necessary to ramp up testing, including the test kits themselves, swabs and reagents, which are chemicals needed to analyze tests.
Sweden's decision to avoid a strict lockdown like its European neighbors drew global attention and was not without controversy, but its chief epidemiologist says there are few things he would have done differently.
A number of European airlines have dropped their financial guidance for the year, as the ongoing coronavirus pandemic creates widespread uncertainty about when business will return to normal.
With the death count from Covid-19 at near-260,000 globally, scientists are scrambling to develop a vaccine. CNBC's Senior Health and Science Reporter Meg Tirrell weighs in on the most promising treatments right now and how the pandemic may affect future drug development.
A team of international experts said that while there was no "magic bullet" for treating Covid-19, successfully identifying a drug that could treat the virus was likely to take less time than rolling out a vaccine.
With the cruising industry in tatters and the desire for remote travel greater than ever, chartering a yacht can sound appealing. Here's what you get for $5,000 to $150,000.
The majority of citizens feel dissatisfied with their leaders' response to the coronavirus outbreak, according to a new report, as countries across the globe have been left grappling with the fallout of the crisis.
Peloton's revenue surged 66% during the fiscal third quarter, as more people purchased its fitness equipment and tuned into its live classes, to try to break a sweat while stuck at home during the coronavirus pandemic.
"We view this as a massive opportunity for us to drive trial and win consumers over into our segment," Beyond Meat CEO Ethan Brown said in a "Mad Money" interview.
Hospitals and physicians around the country are sharply criticizing the federal government for the uneven and opaque way it is distributing its supply of the Covid-19 drug remdesivir.